<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="chchd10-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">chchd10-dis</book-part-id>
      <title-group>
        <title><italic toggle="yes">CHCHD10</italic>-Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ait-El-Mkadem</surname>
            <given-names>Samira</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Reference Center of Mitochondrial Disorders <break/>Nice Hospital<break/>Nice, France</aff>
          <email>saadi.s@chu-nice.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chaussenot</surname>
            <given-names>Annabelle</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Reference Center of Mitochondrial Disorders <break/>Nice Hospital<break/>Nice, France</aff>
          <email>chaussenot.a@chu-nice.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bannwarth</surname>
            <given-names>Sylvie</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Reference Center of Mitochondrial Disorders <break/>Nice Hospital<break/>Nice, France</aff>
          <email>bannwarth.s@chu-nice.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rouzier</surname>
            <given-names>C&#x000e9;cile</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Reference Center of Mitochondrial Disorders <break/>Nice Hospital<break/>Nice, France</aff>
          <email>rouzier.c@chu-nice.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Paquis-Flucklinger</surname>
            <given-names>V&#x000e9;ronique</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Reference Center of Mitochondrial Disorders <break/>Nice Hospital<break/>Nice, France</aff>
          <email>paquis@unice.fr</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>1</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="charge" document-type="chapter">CHARGE Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="chd2-dis" document-type="chapter"><italic toggle="yes">CHD2</italic>-Related Neurodevelopmental Disorders</related-object>
      <abstract id="chchd10-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">CHCHD10</italic>-related disorders are characterized by a spectrum of adult-onset neurologic findings that can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Mitochondrial myopathy (may also be early-onset): weakness, amyotrophy, exercise intolerance</p>
            </list-item>
            <list-item>
              <p>Amyotrophic lateral sclerosis (ALS): progressive degeneration of upper motor neurons (UMNs) and lower motor neurons (LMNs)</p>
            </list-item>
            <list-item>
              <p>Frontotemporal dementia (FTD): slowly progressive behavioral changes, language disturbances, cognitive decline, extrapyramidal signs</p>
            </list-item>
            <list-item>
              <p>Late-onset spinal motor neuronopathy (SMAJ): weakness, cramps and/or fasciculations; areflexia</p>
            </list-item>
            <list-item>
              <p>Cerebellar ataxia: gait ataxia, kinetic ataxia (progressive loss of coordination of lower- and upper-limb movements), dysarthria/dysphagia, nystagmus, cerebellar oculomotor disorder</p>
            </list-item>
          </list>
          <p>Because of the recent discovery <italic toggle="yes">CHCHD10</italic>-related disorders and the limited number of affected individuals reported to date, the natural history of these disorders (except for SMAJ caused by the p.Gly66Val pathogenic variant) is largely unknown.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is established when a heterozygous <italic toggle="yes">CHCHD10</italic> pathogenic variant is detected in an individual with one or more characteristic clinical findings.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Adequate nutrition and weight maintenance are essential. Appropriate bracing and stretching can minimize joint contractures, which are often painful and can interfere with care-giving. Those with weakness benefit from assistance with ambulation and posture. Management of ALS, FTD, SMA, and cerebellar ataxia is the same as for other causes of these disorders.</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular evaluations to detect manifestations that can occur with time including neurologic deficits, psychiatric abnormalities, impaired respiratory function, and sensorineural hearing loss.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Baclofen (used to treat spasticity) can sometimes worsen muscle weakness; some drugs used to treat the behavioral manifestations of FTD may worsen dysarthria, dysphagia, and/or respiratory weakness.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">CHCHD10</italic>-related disorders are inherited in an autosomal dominant manner. Many individuals diagnosed with a <italic toggle="yes">CHCHD10</italic>-related disorder have an affected parent. The proportion of <italic toggle="yes">CHCHD10</italic>-related disorders caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. Each child of an individual with a <italic toggle="yes">CHCHD10</italic>-related disorder has a 50% chance of inheriting the <italic toggle="yes">CHCHD10</italic> pathogenic variant. Prenatal testing for pregnancies at increased risk is possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="chchd10-dis.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="chchd10-dis.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_chchd10-dis.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">CHCHD10</italic>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_chchd10-dis.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Mitochondrial myopathy</p></list-item><list-item><p>Amyotrophic lateral sclerosis (ALS)</p></list-item><list-item><p>Frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS)</p></list-item><list-item><p>Late-onset spinal motor neuronopathy (SMAJ)</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="chchd10-dis.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes, see <xref ref-type="sec" rid="chchd10-dis.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="chchd10-dis.Diagnosis">
        <title>Diagnosis</title>
        <sec id="chchd10-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>A <italic toggle="yes">CHCHD10</italic>-related disorder <bold>should be suspected</bold> in an individual with <bold>clinical findings</bold> of a mitochondrial myopathy, amyotrophic lateral sclerosis, frontotemporal dementia, or late-onset spinal motor neuronopathy especially when the <bold>family history</bold> of these diverse phenotypes is consistent with autosomal dominant inheritance (including apparently sporadic cases).</p>
          <p>Note: Cerebellar ataxia may be present in combination with mitochondrial myopathy, ALS, and/or FTD.</p>
          <sec id="chchd10-dis.Clinical_Findings">
            <title>Clinical Findings</title>
            <p>
              <bold>Mitochondrial myopathy</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Signs of muscle weakness (proximal, axial, and/or facial, including ptosis), amyotrophy, or symptoms that suggest respiratory chain dysfunction, such as exercise intolerance</p>
              </list-item>
            </list>
            <p>
              <bold>Amyotrophic lateral sclerosis (ALS)</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Characteristic signs and symptoms of progressive degeneration of upper motor neurons (UMNs) and lower motor neurons (LMNs)</p>
              </list-item>
              <list-item>
                <p>UMN manifestations include stiffness, spasticity, hyperreflexia, Babinski sign, and pseudobulbar palsy (dysphagia and dysarthria)</p>
              </list-item>
              <list-item>
                <p>LMN manifestations include weakness accompanied by muscle atrophy, fasciculations, areflexia, and cramping</p>
              </list-item>
            </list>
            <p>Note: Most individuals with <italic toggle="yes">CHCHD10</italic>-related ALS meet El Escorial criteria for ALS [<xref ref-type="bibr" rid="chchd10-dis.REF.brooks.2000.293">Brooks et al 2000</xref>] and have both UMN and LMN involvement. (See also the <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">Amyotrophic Lateral Sclerosis Overview</related-object>.)</p>
            <p>
              <bold>Frontotemporal dementia (FTD)</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Slowly progressive behavioral changes (disinhibition, loss of initiative, loss interest in his environment, psychiatric symptoms) [<xref ref-type="bibr" rid="chchd10-dis.REF.bird.1999.741">Bird et al 1999</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.mioshi.2010.1591">Mioshi et al 2010</xref>]</p>
              </list-item>
              <list-item>
                <p>Language disturbances (word-finding difficulties and semantic paraphasias, perseveration, and echolalia, mutism) [<xref ref-type="bibr" rid="chchd10-dis.REF.gornotempini.2011.1006">Gorno-Tempini et al 2011</xref>]</p>
              </list-item>
              <list-item>
                <p>Cognitive decline (executive dysfunctions, attention disorders, and abstract reasoning inability)</p>
              </list-item>
              <list-item>
                <p>Extrapyramidal signs (rigidity, bradykinesia)</p>
              </list-item>
            </list>
            <p>
              <bold>Late-onset spinal motor neuronopathy (SMN) or spinal muscular atrophy, Jokela type (SMAJ)</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>LMN manifestations including: weakness, cramps, and/or fasciculations that are more proximal than distal; areflexia</p>
              </list-item>
            </list>
            <p>
              <bold>Cerebellar ataxia</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Gait ataxia</p>
              </list-item>
              <list-item>
                <p>Kinetic ataxia (progressive loss of coordination of lower- and upper-limb movements)</p>
              </list-item>
              <list-item>
                <p>Dysarthria</p>
              </list-item>
              <list-item>
                <p>Dysphagia</p>
              </list-item>
              <list-item>
                <p>Nystagmus</p>
              </list-item>
              <list-item>
                <p>Cerebellar oculomotor disorder</p>
              </list-item>
            </list>
          </sec>
          <sec id="chchd10-dis.Supportive_Laboratory_Findin">
            <title>Supportive Laboratory Findings</title>
            <p>Although none of the following laboratory findings is specific, all could be considered supportive findings.</p>
            <p>
              <bold>Neuroimaging</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Frontal and/or temporal atrophy on brain CT or MRI [<xref ref-type="bibr" rid="chchd10-dis.REF.foster.1997.706">Foster et al 1997</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.van_swieten.1999.617">van Swieten et al 1999</xref>].</p>
              </list-item>
              <list-item>
                <p>Decrease of cerebral perfusion anteriorly (single-photon emission computed tomography [SPECT]).</p>
              </list-item>
              <list-item>
                <p>Frontotemporal hypometabolism (positron emission tomography with <sup>18</sup>F-fluorodeoxyglucose [FDG-PET]) [<xref ref-type="bibr" rid="chchd10-dis.REF.foster.2007.2616">Foster et al 2007</xref>].</p>
              </list-item>
              <list-item>
                <p>Reduced striatal uptake of <sup>18</sup>F-fluoro-L-dopa [<xref ref-type="bibr" rid="chchd10-dis.REF.wszolek.1992.312">Wszolek et al 1992</xref>].</p>
              </list-item>
            </list>
            <p><bold>Muscle biopsy</bold> findings that support the diagnosis of a mitochondrial myopathy are ragged-red and/or COX negative fibers with or without multiple mtDNA deletions. Note that a muscle biopsy is not required for diagnosis of a <italic toggle="yes">CHCHD10</italic>-related disorder.</p>
            <p><bold>Electromyography and nerve conduction studies (EMG/NCS</bold>) demonstrate widespread denervation due to LMN loss in the setting of relatively preserved sensory responses [<xref ref-type="bibr" rid="chchd10-dis.REF.gitcho.2008.535">Gitcho et al 2008</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.k_hnlein.2008.1185">K&#x000fc;hnlein et al 2008</xref>].</p>
            <p><bold>Serum CK concentration</bold> is normal or high.</p>
          </sec>
        </sec>
        <sec id="chchd10-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">CHCHD10</italic>-related disorder <bold>is established</bold> when a heterozygous pathogenic variant is detected in <italic toggle="yes">CHCHD10</italic> (<xref ref-type="table" rid="chchd10-dis.T.molecular_genetic_testing">Table 1</xref>) in a proband with one or more of the above clinical findings.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing</bold>. Sequence analysis of <italic toggle="yes">CHCHD10</italic> is most appropriate in individuals whose family history suggests a <italic toggle="yes">CHCHD10-</italic>related disorder and in individuals in whom other more common molecular causes of ALS / FTD-ALS / MND (motor neuron disease) have already been ruled out.To date no <italic toggle="yes">CHCHD10</italic> deletions/duplications have been reported.</p>
              <p>Targeted analysis for the p.Gly66Val pathogenic variant can be performed first in individuals of Finnish ancestry with late-onset spinal motor neuronopathy (SMN) (SMAJ) [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CHCHD10</italic> and other genes of interest (see <xref ref-type="sec" rid="chchd10-dis.Differential_Diagnosis">Differential Diagnosis</xref>) can also be considered as the initial test. Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">CHCHD10</italic>) fails to confirm a diagnosis in an individual with features of a <italic toggle="yes">CHCHD10</italic>-related disorder. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="chchd10-dis.T.molecular_genetic_testing" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">CHCHD10</italic>-related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">CHCHD10</italic>
                  </td>
                  <td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">All pathogenic variants reported to date&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_chchd10-dis.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported to date</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="chchd10-dis.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="chchd10-dis" object-id="chchd10-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="chchd10-dis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="chchd10-dis.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="chchd10-dis.TF.1.3">
                <label>3. </label>
                <p>Fewer than ten missense variants have been associated with a <italic toggle="yes">CHCHD10-</italic>related disorder. A founder variant (<xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Gly66Val</xref>) was identified in 55 individuals from 17 Finnish families [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>]. The <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Arg15Leu</xref> pathogenic variant was identified in six of 213 families with ALS [<xref ref-type="bibr" rid="chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>]. Additional missense variants were identified in families [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</xref>] and simplex cases (a single occurrence in a family) [<xref ref-type="bibr" rid="chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</xref>].</p>
              </fn>
              <fn id="chchd10-dis.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="chchd10-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="chchd10-dis.Clinical_Description">
          <title>Clinical Description</title>
          <p>The phenotypic spectrum of <italic toggle="yes">CHCHD10-</italic>related disorders is broad and can include any of the following alone or in any combination: mitochondrial myopathy, amyotrophic lateral sclerosis, frontotemporal dementia, and late-onset spinal motor neuronopathy. Cerebellar ataxia may also be found in combination with these disorders, but not as the sole neurologic manifestation.</p>
          <p><italic toggle="yes">CHCHD10</italic> pathogenic variants were originally identified in: (1) a large family with late-onset frontotemporal dementia (FTD), motor neuron disease (MND), cerebellar ataxia, and mitochondrial myopathy with mtDNA deletions [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>] and (2) a large family with early-onset mitochondrial myopathy without mtDNA deletions [<xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>].</p>
          <p><italic toggle="yes">CHCHD10</italic> pathogenic variants have also been described in individuals with frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) and familial and sporadic pure ALS [<xref ref-type="bibr" rid="chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</xref>].</p>
          <p>More recently, a <italic toggle="yes">CHCHD10</italic> founder variant has been identified in 17 Finnish families with late-onset spinal motor neuronopathy (SMAJ) [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>].</p>
          <p>Because of the recent discovery of <italic toggle="yes">CHCHD10</italic>-related disorders and the limited number of affected individuals reported to date, the natural history of these disorders (except for late-onset spinal motor neuronopathy (SMAJ) caused by the p.Gly66Val pathogenic variant) is largely unknown.</p>
          <p><bold>Mitochondrial myopathy</bold> may present with exercise intolerance; proximal, axial, and/or facial muscle weakness; ptosis; and amyotrophy. Deafness may also be observed.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Early-onset</bold>. In a Puerto Rican family, affected individuals had myopathy (appearing in the first decade of life) and short stature [<xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Late-onset.</bold> In a French family, affected individuals had late-onset myopathy with MND, FTD, and cerebellar ataxia [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>.</p>
            </list-item>
          </list>
          <p><bold>Amyotrophic lateral sclerosis</bold>
<bold>(ALS).</bold> The manifestations of ALS in <italic toggle="yes">CHCHD10</italic>-related disorders appear to overlap significantly with idiopathic and <italic toggle="yes">SOD1</italic>-related ALS (see <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>), including gender ratio, age of onset, symptom distribution, and severity of disease. Mean age of onset is 53 years (age range 25-75 years).</p>
          <p>Although presentations of ALS of various etiologies may overlap, in <italic toggle="yes">CHCHD10</italic>-related ALS phenotypes the upper limbs seem to be more frequently involved at the onset and in <italic toggle="yes">CHCHD10</italic>-related FTD-ALS bulbar involvement is more predominant.</p>
          <p>Bulbar dysfunction (atrophy of facial and masticatory muscles, perioral fasciculations, and severe dysphagia leading to frequent aspiration) become prominent in the final stages of the disease. Affected individuals eventually develop respiratory failure, which is the main cause of death.</p>
          <p>Intra- and interfamilial variability is observed even with the same <italic toggle="yes">CHCHD10</italic> pathogenic variant. Mean disease duration prior to death is 8.6 years (range 2-17 years).</p>
          <p>Note: <italic toggle="yes">CHCHD10-</italic>related ALS is clinically indistinguishable from ALS of other causes. However, based on published data, <italic toggle="yes">CHCHD10-</italic>related ALS may include upper limb onset, flail-arm syndrome, and bulbar signs [<xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2015.e377">Bannwarth et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</xref>]. Nevertheless, even within a family, clinical variability is considerable, especially regarding age of onset and longevity.</p>
          <p><bold>Frontotemporal dementia (FTD)</bold> is a presenile dementia affecting the frontal and temporal cortex and some subcortical nuclei. Clinical presentation is variable. Affected individuals may have slowly progressive behavioral changes, language disturbance, and/or extrapyramidal signs. In individuals with <italic toggle="yes">CHCHD10</italic>-related FTD, symptoms started between ages 50 and 67 years. Disease duration was usually between four and 27 years. The disease progresses over a few years into profound dementia with mutism.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Behavioral changes.</bold> Disinhibition and loss of initiative are the most common presenting symptoms. Affected individuals lose interest in their environment and neglect their personal hygiene. Obsessive-compulsive behavior and delusions or hallucinations are early clinical features in some. Roaming, restlessness, verbal aggressiveness, hyperorality (including alcohol abuse), and financial mismanagement are frequently seen [<xref ref-type="bibr" rid="chchd10-dis.REF.foster.1997.706">Foster et al 1997</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.bird.1999.741">Bird et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Psychiatric manifestations.</bold> Persecutory delusions and visual or auditory hallucinations occur rarely in FTD and were not reported in individuals with mutation of <italic toggle="yes">CHCHD10</italic>.</p>
            </list-item>
            <list-item>
              <p><bold>Cognitive decline.</bold> Word-finding difficulties and semantic paraphasias in conversational speech are common early findings. Orientation in time and place, visuo-constructive functions, and short-term memory remain intact initially. Executive functions, attention, concentration, and abstract reasoning ability become impaired in all affected individuals. Language comprehension remains relatively preserved over the course of the disease. Perseveration, repetitive utterances, and echolalia lead to mutism after several years [<xref ref-type="bibr" rid="chchd10-dis.REF.foster.1997.706">Foster et al 1997</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Extrapyramidal signs.</bold> Affected individuals may show parkinsonian signs inlcuding decreased facial expression, bradykinesia, postural instability, and rigidity without resting tremor. The extrapyramidal signs are unresponsive or only partially responsive to L-dopa treatment.</p>
            </list-item>
          </list>
          <p><bold>Spinal motor neuronopathy</bold> in <italic toggle="yes">CHCHD10</italic>-related disorders (SMAJ) is characterized by late onset. Affected individuals develop cramps and fasciculations, slowly progressive and predominantly lower limb weakness, and diminished or absent deep tendon reflexes; respiratory symptoms are absent. Mild, non-progressive dysphagia appears later in the disease course in 13% of affected individuals. About half of affected individuals develop mild reduction in sensory nerve amplitudes or reduced vibration sense in the distal lower limbs usually later in the disease course. Affected individuals remain ambulant for several decades after onset [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>].</p>
          <p><bold>Cerebellar ataxia</bold> in <italic toggle="yes">CHCHD10</italic>-related disorders is characterized by ataxia, dysarthria, and eventual deterioration of bulbar functions. Onset is in the sixth decade. Affected individuals have difficulties in gait and slurred speech. They may first notice problems of balance in going down stairs or making sudden turns. In the early stages of disease affected individuals may display brisk deep tendon reflexes, hypermetric saccades, and nystagmus [<xref ref-type="bibr" rid="chchd10-dis.REF.schmitzh_bsch.2006.1717">Schmitz-H&#x000fc;bsch et al 2006</xref>]. Mild dysphagia, indicated by choking on food and drink, may also occur early in the disease.</p>
          <p>As the disease progresses saccadic velocity slows and up-gaze palsy develops. Nystagmus often disappears with evolving saccadic abnormalities.</p>
          <p>As the ataxia worsens, other cerebellar signs such as dysmetria, dysdiadochokinesia, and hypotonia become apparent.</p>
          <p><bold>Neuropathology.</bold> To date no study of brain pathology has been performed in an individual with a <italic toggle="yes">CHCHD10</italic>-related disorder.</p>
        </sec>
        <sec id="chchd10-dis.GenotypePhenotype_Correlatio">
          <title>Genotype-Phenotype Correlations</title>
          <p>No obvious genotype-phenotype correlation exists.</p>
          <p>The clinical course of <italic toggle="yes">CHCHD10</italic>-related disorders is highly variable, even within a family, and is not predictable from the type or location of the pathogenic variant.</p>
          <p>The same <italic toggle="yes">CHCHD10</italic> pathogenic variant can lead to different phenotypes; for example, individuals with the p.Ser59Leu pathogenic variant had different findings including ataxia and/or FTD and/or ALS; the only element common to all affected individuals from the large French family was the laboratory finding of a mitochondrial myopathy with numerous ragged-red and COX-negative fibers associated with multiple mtDNA deletions [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>]. No muscle biopsy was available from the affected individual with the same pathogenic variant reported by <xref ref-type="bibr" rid="chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al [2014]</xref>.</p>
          <p>However, it should be noted that:</p>
          <list list-type="bullet">
            <list-item>
              <p>The <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Arg15Leu</xref> pathogenic variant appears to predominate in familial pure ALS [<xref ref-type="bibr" rid="chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>The p.Arg15Leu and <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Pro80Leu</xref> variants may be associated with fly-arm or predominant upper-limb involvement [<xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>The <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Gly66Val</xref> pathogenic variant was identified as a founder variant in 17 Finnish families with SMAJ [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>]. Bulbar symptoms, mitochondrial myopathy, and cognitive dysfunction were exceptional findings in SMAJ even after decades of follow up, in contrast to individuals with the <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Ser59Leu</xref> pathogenic variant, for whom these were the most prominent clinical features [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.chaussenot.2014.2884.e1">Chaussenot et al 2014</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="chchd10-dis.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is difficult to estimate because few unaffected individuals in families with a <italic toggle="yes">CHCHD10</italic>-related disorder have been genotyped or longitudinally followed for the emergence of symptoms.</p>
          <p>Complete penetrance was described in all families with a <italic toggle="yes">CHCHD10</italic> pathogenic variant [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>] except two families with ALS and the <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Arg15Leu</xref> variant [<xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>] and one with the p.Pro34Ser variant [<xref ref-type="bibr" rid="chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</xref>]. More reports will be needed before the penetrance can be more accurately established.</p>
        </sec>
        <sec id="chchd10-dis.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of <italic toggle="yes">CHCHD10</italic>-related disorders is not known at present. However, based on the first published series, prevalence of <italic toggle="yes">CHCHD10-</italic>related disorders is estimated at 1.4%-3.5% in individuals of European ancestry with ALS or the FTD-ALS spectrum [<xref ref-type="bibr" rid="chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</xref>].</p>
          <p>Mutation of <italic toggle="yes">CHCHD10</italic> appears to rank immediately following mutation of <italic toggle="yes">C9ORF72</italic> and <italic toggle="yes">SOD1</italic> as a cause of sporadic ALS [<xref ref-type="bibr" rid="chchd10-dis.REF.renton.2011.257">Renton et al 2011</xref>].</p>
          <p><italic toggle="yes">CHCHD10 p</italic>athogenic variants have been identified in individuals from different geographic regions, including America and Europe.</p>
        </sec>
      </sec>
      <sec id="chchd10-dis.Genetically_Related_Allelic">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">CHCHD10.</italic></p>
      </sec>
      <sec id="chchd10-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Mitochondrial myopathy.</bold> For a detailed discussion and the differential diagnosis of mitochondrial myopathy, see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
        <p><bold>Sporadic and familial ALS.</bold> For a detailed discussion of these disorders and the differential diagnosis of ALS, see <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">Amyotrophic Lateral Sclerosis Overview</related-object>.</p>
        <p><bold>Familial ALS (FALS)</bold> (i.e., presence of at least two affected family members)</p>
        <list list-type="bullet">
          <list-item>
            <p>Because approximately 20% of FALS is caused by mutation of <italic toggle="yes">SOD1</italic> and approximately 30% by mutation of <italic toggle="yes">C9ORF72</italic>, a tiered approach to testing a proband with autosomal dominant FALS should begin with <italic toggle="yes">C9ORF72</italic>
<bold>and</bold>
<italic toggle="yes">SOD1</italic> sequencing.</p>
          </list-item>
          <list-item>
            <p>If neither a <italic toggle="yes">C9ORF72</italic> nor a <italic toggle="yes">SOD1</italic> pathogenic variant is identified, sequencing of <italic toggle="yes">CHCHD10</italic> should be performed. Based on published data available to date, variants in <italic toggle="yes">CHCHD10</italic> appear to be the third most common cause of FALS [<xref ref-type="bibr" rid="chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</xref>].</p>
          </list-item>
          <list-item>
            <p>Although in some instances testing for other rare genetic causes of FALS can be considered, these disorders have a distinctive clinical presentation or autosomal recessive inheritance pattern (see <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">Amyotrophic Lateral Sclerosis Overview</related-object>).</p>
          </list-item>
        </list>
        <p><bold>Sporadic ALS (SALS)</bold> (i.e., single occurrence in a family). Sequencing of <italic toggle="yes">CHCHD10</italic> in SALS can be performed.</p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al [2015]</xref> also identified the <italic toggle="yes">CHCHD10</italic> variants p.Pro34Ser (2 patients) and p.Pro80Leu (1 patient) in Italians with sporadic ALS/FTD-ALS corresponding to 1.4% of Italians with a diagnosis of probable or definite motor neuron disease.</p>
          </list-item>
          <list-item>
            <p>In the data sets of <xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al [2015]</xref> the estimated mutation frequency is 1.2% for sporadic ALS.</p>
          </list-item>
        </list>
        <p><bold>Sporadic or familial FTD-ALS</bold> (i.e., presence of at least two affected family members)</p>
        <list list-type="bullet">
          <list-item>
            <p>Because FTD/ALS is mainly caused by mutation of <italic toggle="yes">C9ORF72, MAPT, FUS1, GRN, TARDBP,</italic> and <italic toggle="yes">VCP,</italic> a tiered approach to testing a proband with autosomal dominant familial FTD-ALS should begin with sequencing of these genes.</p>
          </list-item>
          <list-item>
            <p>If no pathogenic variant is identified in <italic toggle="yes">C9ORF72, MAPT, FUS1, GRN, TARDBP,</italic> or <italic toggle="yes">VCP</italic>, sequencing of <italic toggle="yes">CHCHD10</italic> should then be performed.</p>
          </list-item>
        </list>
        <p><italic toggle="yes">CHCHD10</italic>-associated ALS must be differentiated from mimics of ALS. Detailed clinical evaluation (as outlined above) usually allows the exclusion of other disorders. The rate of misdiagnosis in ALS is highest in individuals presenting with purely lower motor neuron findings [<xref ref-type="bibr" rid="chchd10-dis.REF.traynor.2000.109">Traynor et al 2000</xref>].</p>
        <p>Disorders of any cause that mimic ALS are numerous and include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Multifocal motor neuropathy</p>
          </list-item>
          <list-item>
            <p>Cervical spondylosis</p>
          </list-item>
          <list-item>
            <p>Adult-onset <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">spinal muscular atrophy</related-object> (SMA)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">Kennedy disease</related-object> (X-linked spinobulbar muscular atrophy [SBMA])</p>
          </list-item>
          <list-item>
            <p>Acquired and hereditary motor neuropathies (see <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object>)</p>
          </list-item>
          <list-item>
            <p>Late-onset GM2 gangliosidosis (see <related-object link-type="booklink" source-id="gene" document-id="tay-sachs" document-type="chapter">Hexosaminidase A Deficiency</related-object>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="apbd" document-type="chapter">Adult polyglucosan body disease</related-object>
            </p>
          </list-item>
        </list>
        <p>See <xref ref-type="table" rid="chchd10-dis.T.other_genes_associated_wit">Table 2</xref> for a list of other genes associated with FALS.</p>
        <table-wrap id="chchd10-dis.T.other_genes_associated_wit" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Other Genes Associated with FALS</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Selected <italic toggle="yes">GeneReview</italic></th>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein</th>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Selected OMIM</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">ANG</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Angiogenin</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/611895">611895</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">DCTN1</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Dynactin</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/105400">105400</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">FUS/TLS</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Fused in sarcoma/translated in liposarcoma</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608030">608030</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">SETX</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Senataxin</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/602433">602433</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">SOD1</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Superoxide dismutase [Cu-Zn]</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/105400">105400</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">TARDBP</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="tardbp-als" document-type="chapter"><italic toggle="yes">TARDBP</italic>-Related ALS</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">TAR DNA-binding protein 43</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612069">612069</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">VAPB</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">ALS Overview</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Vesicle-associated membrane protein-associated protein B/C</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608627">608627</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">VCP</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="ibmpfd" document-type="chapter">Inclusion Body Myopathy w/Paget Disease of Bone and/or FTD</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Transitional endoplasmic reticulum ATPase</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613954">613954</ext-link>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Pathogenic variants in many of these genes have also been identified in small numbers of simplex cases of ALS (i.e., a single occurrence of ALS in a family).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>FTD-ALS.</bold> Structural imaging may show focal atrophy and may exclude other causes of dementia (e.g., frontal meningioma, chronic subdural hematoma).</p>
        <p>The disorders of any cause that mimic FTD include:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer disease</related-object> when individuals present with mild behavioral changes, prominent memory disturbance and loss of initiative, or word-finding problems in the absence of evident frontotemporal atrophy on neuroimaging.</p>
          </list-item>
          <list-item>
            <p>Familial Parkinson disease when parkinsonism is present (see <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>). Other familial neurologic diseases associated with dementia or parkinsonian features including <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>, dementia with Lewy bodies, and <related-object link-type="booklink" source-id="gene" document-id="prion" document-type="chapter">prion diseases</related-object> also need to be considered.</p>
          </list-item>
        </list>
        <p>Non-genetic acquired causes of dementia should always be considered.</p>
        <p>About 25% of persons with FTD have a positive family history and demonstrate an autosomal dominant pattern of inheritance.</p>
        <p>See <xref ref-type="table" rid="chchd10-dis.T.other_genes_associated_wit_1">Table 3</xref> for a list of other genes associated with FTD-ALS.</p>
        <table-wrap id="chchd10-dis.T.other_genes_associated_wit_1" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Other Genes Associated with FTD-ALS</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Selected <italic toggle="yes">GeneReview</italic></th>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein</th>
                <th id="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Selected OMIM</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">C9orf72</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="als-ftd" document-type="chapter"><italic toggle="yes">C9orf72</italic>-Related ALS &#x00026; FTD</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Uncharacterized protein C9orf72</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/105550">105550</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">CHMP2B</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="ftd-chmp2b" document-type="chapter">FTD, Chromosome 3-Linked</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Charged multivesicular body protein 2b</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600795">600795</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">GRN (PGRN)</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="ftd-grn" document-type="chapter"><italic toggle="yes">GRN</italic>-Related FTD</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Granulins</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/607485">607485</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">MAPT</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter"><italic toggle="yes">MAPT</italic>-Related Disorders</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Microtubule-associated protein tau</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600274">600274</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">TARDBP</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="tardbp-als" document-type="chapter"><italic toggle="yes">TARDBP</italic>-Related ALS</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">TAR DNA-binding protein 43</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612069">612069</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">VCP</italic>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="ibmpfd" document-type="chapter">Inclusion Body Myopathy w/Paget Disease of Bone and/or FTD</related-object>
                </td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Valosin-containing protein</td>
                <td headers="hd_h_chchd10-dis.T.other_genes_associated_wit_1_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/167320">167320</ext-link>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Pathogenic variants in many of these genes have also been identified in small numbers of simplex cases of ALS (i.e., a single occurrence in a family).</p>
            </fn>
            <fn>
              <p>FTD = frontotemporal dementia</p>
            </fn>
            <fn>
              <p>ALS = amyotrophic lateral sclerosis</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Cerebellar ataxia.</bold> For a detailed discussion and the differential diagnosis of inherited ataxias myopathy, see <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object>.</p>
      </sec>
      <sec id="chchd10-dis.Management">
        <title>Management</title>
        <sec id="chchd10-dis.Evaluations_Following_Initia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with a <italic toggle="yes">CHCHD10</italic>-related disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>A structured general medical history and family history</p>
            </list-item>
            <list-item>
              <p>Physical examination and neurologic examination</p>
            </list-item>
            <list-item>
              <p>EMG/NCS to document the regions of involvement and indicate lower motor neuron and/or myopathic involvement</p>
            </list-item>
            <list-item>
              <p>Evaluation of the extent and profile of cognitive disturbance by neuropsychological examination</p>
            </list-item>
            <list-item>
              <p>Neuroimaging with MRI if not done at time of initial diagnosis.</p>
            </list-item>
            <list-item>
              <p>Pulmonary function testing to detect and stage respiratory involvement</p>
            </list-item>
            <list-item>
              <p>Speech and swallowing evaluation if dysarthria and/or dysphagia are present to direct care to minimize risk of aspiration and to initiate augmentative communication strategies for possible loss of verbal communication</p>
            </list-item>
            <list-item>
              <p>Audiologic examination, including auditory brain stem responses (ABRs) and evoked otoacoustic emissions</p>
            </list-item>
            <list-item>
              <p>Physical and occupational therapy evaluation to determine the adaptive devices needed to maximize function</p>
            </list-item>
            <list-item>
              <p>Nutritional evaluation</p>
            </list-item>
            <list-item>
              <p>Screening to detect depression and assess need for psychosocial support</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="chchd10-dis.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>
            <bold>General</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Adequate nutrition and weight maintenance are essential. Percutaneous gastrostomy is often appropriate to maintain adequate caloric intake in persons with significant bulbar involvement.</p>
            </list-item>
            <list-item>
              <p>Joint contractures can occur, are often painful, and can interfere with care-giving. Appropriate bracing and stretching can minimize contractures.</p>
            </list-item>
          </list>
          <p>
            <bold>Mitochondrial myopathy</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Assistance with ambulation and posture</p>
            </list-item>
            <list-item>
              <p>Surgical correction of ptosis as needed</p>
            </list-item>
          </list>
          <p><bold>Amyotrophic lateral sclerosis</bold>
<bold>(ALS).</bold> The management of <italic toggle="yes">CHCHD10</italic>-related ALS is identical to that of ALS due to other causes, and is outlined in the American Academy of Neurology practice parameter on this topic [<xref ref-type="bibr" rid="chchd10-dis.REF.miller.1999.1311">Miller et al 1999</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Spasticity can be treated with a spasmolytic such as baclofen or a benzodiazepine.</p>
            </list-item>
            <list-item>
              <p>Pseudobulbar affect can be treated with a tricyclic antidepressant or combination of quinidine and dextromethorphan.</p>
            </list-item>
            <list-item>
              <p>Sialorrhea is often managed with anticholinergic medications (tricyclic antidepressants, scopolamine, atropine drops) or botulinum toxin injection of the salivary glands.</p>
            </list-item>
            <list-item>
              <p>Antidepressants are often required to treat concurrent depression.</p>
            </list-item>
            <list-item>
              <p>Riluzole is the only FDA-approved treatment for any type of ALS. Although there are no efficacy data specifically for <italic toggle="yes">CHCHD10</italic>-related ALS, strong consideration should be given to its use.</p>
            </list-item>
          </list>
          <p><bold>Frontotemporal dementia (FTD).</bold> Treatment follows routine practices.</p>
          <list list-type="bullet">
            <list-item>
              <p>Sedative or antipsychotic drugs help to reduce extreme restlessness, roaming behavior, delusions, and hallucinations.</p>
            </list-item>
            <list-item>
              <p>The extrapyramidal signs are usually unresponsive or only partially responsive to L-dopa treatment.</p>
            </list-item>
            <list-item>
              <p>Behavioral changes and the loss of insight and judgment in individuals with FTD often present a considerable burden for partners or other caregivers. Information about the disease and psychological support for partners or other caregivers is essential.</p>
            </list-item>
          </list>
          <p><bold>Spinal motor neuronopathy.</bold> The management of SMAJ is identical to that of adult-onset SMA due to other causes.</p>
        </sec>
        <sec id="chchd10-dis.Surveillance">
          <title>Surveillance</title>
          <p>The following regular evaluations are indicated to detect manifestations that can occur with time:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Neurologic deficits.</bold> Neurologic examination including assessment of memory, personality changes</p>
            </list-item>
            <list-item>
              <p><bold>Psychiatric abnormalities.</bold> Assessment for signs including depression and suicidal ideation</p>
            </list-item>
            <list-item>
              <p><bold>Impaired respiratory function.</bold> Monitoring of forced vital capacity (FEV) and other aspects of respiratory function performed at clinic visits to determine the appropriate time to offer noninvasive ventilation</p>
            </list-item>
            <list-item>
              <p><bold>Sensorineural hearing loss.</bold> Audiologic examination including speech discrimination testing</p>
            </list-item>
          </list>
        </sec>
        <sec id="chchd10-dis.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The following should be noted:</p>
          <list list-type="bullet">
            <list-item>
              <p>Baclofen used to treat spasticity can sometimes worsen muscle weakness.</p>
            </list-item>
            <list-item>
              <p>Some drugs used to treat the behavioral manifestations of FTD may worsen dysarthria, dysphagia, and/or respiratory weakness.</p>
            </list-item>
          </list>
        </sec>
        <sec id="chchd10-dis.Evaluation_of_Relatives_at_R">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="chchd10-dis.Related_Genetic_Counseling_I">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="chchd10-dis.Therapies_Under_Investigatio">
          <title>Therapies Under Investigation</title>
          <p>A clinical trial with the selective serotonin reuptake inhibitor (SSRI) paroxetine showed an increase in cognitive impairment in patients with FTD treated with this drug [<xref ref-type="bibr" rid="chchd10-dis.REF.deakin.2004.400">Deakin et al 2004</xref>]. Conversely, a previous study with another SSRI, trazodone, showed a favorable effect on behavioral disturbances and agitation without cognitive decline [<xref ref-type="bibr" rid="chchd10-dis.REF.lebert.2004.355">Lebert et al 2004</xref>]. Further studies are needed to clarify this issue.</p>
          <p>Several trials with memantine are underway in patients with FTD, as well as a trial with oxytocin and its effect on social cognition.</p>
          <p>Although no current clinical trials are specifically designed to target <italic toggle="yes">CHCHD10</italic>-related disorders, many are addressed in the broader category of ALS or FTD.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="chchd10-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="chchd10-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">CHCHD10</italic>-related disorders are inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="chchd10-dis.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed with a <italic toggle="yes">CHCHD10</italic>-related disorder have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with <italic toggle="yes">CHCHD10</italic>-related disorder may have the disorder as the result of <italic toggle="yes">de novo CHCHD10</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent.</p>
              <list list-type="bullet">
                <list-item>
                  <p>The proportion of <italic toggle="yes">CHCHD10</italic>-related disorders caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
                </list-item>
                <list-item>
                  <p>Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include thorough clinical examination and molecular genetic testing for the <italic toggle="yes">CHCHD10</italic> pathogenic variant identified in the proband.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with a <italic toggle="yes">CHCHD10</italic>-related disorder may appear to be negative because of failure by health care professionals to recognize the disorder in family members and/or milder phenotypic presentation, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical and molecular testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs of inheriting the <italic toggle="yes">CHCHD10</italic> pathogenic variant is 50%.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">CHCHD10</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a <italic toggle="yes">CHCHD10</italic>-related disorder has a 50% chance of inheriting the <italic toggle="yes">CHCHD10</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected or has a <italic toggle="yes">CHCHD10</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="chchd10-dis.Related_Genetic_Counseling_I">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with a <italic toggle="yes">CHCHD10</italic>-related disorder is possible after molecular genetic testing has identified the specific pathogenic variant in the family. Such testing should be performed in the context of formal genetic counseling. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>Testing is appropriate to consider in symptomatic individuals in a family with an established diagnosis of a <italic toggle="yes">CHCHD10</italic>-related disorder regardless of age.</p>
          <p>For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="chchd10-dis.Prenatal_Testing_and_Preimpl">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CHCHD10</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk for a <italic toggle="yes">CHCHD10</italic>-related disorder and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="chchd10-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="chchd10-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">CHCHD10</italic> consists of four exons. Exons 1 and 2 are particularly GC-rich. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="chchd10-dis" object-id="chchd10-dis.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p>Alternative splicing of this gene results in multiple transcripts. The longer transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001301339.1">NM_001301339.1</ext-link> produces an isoform composed of 149 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001288268.1">NP_001288268.1</ext-link>) and the transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_213720.2">NM_213720.2</ext-link> produces a shorter isoform (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_998885.1">NP_998885.1</ext-link>) which is composed of 142 amino acids. See also the UniProtKB/Swiss-Prot reference <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.uniprot.org/entry/Q8WYQ3">Q8WYQ3</ext-link></p>
        <p><italic toggle="yes">CHCHD10</italic> was previously referred to as <italic toggle="yes">C22orf16</italic>.</p>
        <p><bold>Pathogenic variants.</bold>
<italic toggle="yes">CHCHD10</italic> has only recently been associated with disease. To date all identified <italic toggle="yes">CHCHD10</italic> pathogenic variants are located in exon 2. To date no <italic toggle="yes">CHCHD10</italic> deletions/duplications have been reported.</p>
        <p>The pathogenicity of many of these variants has not been proven by functional studies. In addition, <italic toggle="yes">CHCHD10</italic> is often poorly covered in exome data and, therefore, even quite common variants may be absent from databases, complicating the interpretation of variants within this gene.</p>
        <p>The <italic toggle="yes">CHCHD10</italic> variant <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Arg15Leu</xref> was identified in six of 213 families with ALS [<xref ref-type="bibr" rid="chchd10-dis.REF.johnson.2014.e311">Johnson et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.m_ller.2014.e309">M&#x000fc;ller et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.kurzwelly.2015.e376">Kurzwelly et al 2015</xref>]. <xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al [2015]</xref> reported this variant in an individual with simplex ALS (i.e., a single occurrence in a family).</p>
        <p>The p.Arg15Ser variant was found in <italic toggle="yes">cis</italic> configuration with p.Gly58Ser in ten individuals in a Puerto Rican family with mitochondrial myopathy without mtDNA deletions [<xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>].</p>
        <p>The <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.[Arg15Ser;Gly58Arg]</xref> pathogenic variant was identified in a pure early-onset mitochondrial myopathy [<xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>]. Biochemical analysis showed respiratory chain dysfunction in muscle biopsies from affected individuals. The expression of the p.Gly58Arg, but not p.Arg15Ser, pathogenic variant in transfected cultured cells induced mitochondrial fragmentation. Because the variant is adjacent to p.Ser59Leu, this part of the protein is hypothesized to likely be of importance to mitochondrial function [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>].</p>
        <p>The p.Ser59Leu pathogenic variant was first identified in a large family in which affected individuals presented with atypical FTD/ALS and mitochondrial myopathy [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>]. In all affected individuals, muscle biopsy showed ragged-red and COX-negative fibers with combined respiratory chain deficiency and abnormal assembly of complex V. The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. Fibroblasts from affected individuals showed respiratory chain deficiency, mitochondrial ultrastructural alterations, and fragmentation of the mitochondrial network [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>]. Overexpression of the <italic toggle="yes">CHCHD10</italic> pathogenic variant in HeLa cells led to fragmentation of the mitochondrial network and major ultrastructural abnormalities including loss, disorganization, and dilatation of cristae. As a polar residue of the hydrophobic helix, amino acid Ser59 may intervene in hydrogen bonds to stabilize CHCHD10 interaction with another protein.</p>
        <p>The founder variant <xref ref-type="table" rid="chchd10-dis.T.chchd10_variants_discussed">p.Gly66Val</xref> was identified in 55 individuals from 17 Finnish families [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>]. The variant p.Gly66Val is a cause of late-onset spinal motor neuronopathy (SMAJ). Because valine is larger in size than glycine, it has been suggested that the bulkier valine molecule could affect the overall structure of the hydrophobic helix [<xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>].</p>
        <p><xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al [2015]</xref> described the p.Pro80Leu variant in an individual with familial ALS and in an individual with simplex ALS (i.e., a single occurrence in a family). <xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al [2015]</xref> described the same variant in two individuals with simplex ALS. Respiratory chain analysis performed on skeletal muscle of an affected individual with early-onset simplex ALS with the <italic toggle="yes">CHCHD10</italic> p.Pro80Leu variant revealed combined respiratory chain deficiency and a severe mitochondrial myopathy; further functional analysis would be helpful for validation of its pathogenicity [<xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al 2015</xref>]. This variant has also been observed in the general population (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://exac.broadinstitute.org">exac.broadinstitute.org</ext-link>).</p>
        <p>Testing of 115 unrelated individuals with FTD-ALS identified two unrelated individuals with a p.Pro34Ser variant [Chaussenot el al 2014]. <xref ref-type="bibr" rid="chchd10-dis.REF.ronchi.2015.e372">Ronchi et al [2015]</xref> also identified the same variant in an individual with ALS (of 224 tested). Although the p.Pro34Ser is present in the normal population, it does not segregate with the disease [<xref ref-type="bibr" rid="chchd10-dis.REF.dobsonstone.2015.e385">Dobson-Stone et al 2015</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.zhang.2015.e380">Zhang et al 2015</xref>]; however, functional studies favor its pathogenicity [personal data, manuscript submitted].</p>
        <table-wrap id="chchd10-dis.T.chchd10_variants_discussed" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p><italic toggle="yes">CHCHD10</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.44G&#x0003e;T</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg15Leu</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_3" rowspan="8" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001301339.1">NM_001301339.1</ext-link>&#x000a0;<sup>1</sup><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001288268.1">NP_001288268.1</ext-link>&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.67C&#x0003e;A</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro23Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.100C&#x0003e;T</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro34Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.104C&#x0003e;A</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala35Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.176C&#x0003e;T</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser59Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.197G&#x0003e;T</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly66Val</td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.239C&#x0003e;T</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro80Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.[43C&#x0003e;G;172G&#x0003e;C]</td>
                <td headers="hd_h_chchd10-dis.T.chchd10_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.[Arg15Ser;Gly58Arg]</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="chchd10-dis.TF.4.1">
              <label>1. </label>
              <p>Nucleotide and amino acid changes for pathogenic variants are numbered the same for alternate reference sequences <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_213720.2">NM_213720.2</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_998885.1">NP_998885.1</ext-link>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> CHCHD10, a small mitochondrial protein encoded by the nuclear gene <italic toggle="yes">CHCHD10</italic>, belongs to a family of mitochondrial proteins characterized by conserved CXnX motifs, some of which are involved in cristae integrity and mitochondrial fusion [<xref ref-type="bibr" rid="chchd10-dis.REF.darshi.2011.2918">Darshi et al 2011</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.an.2012.7411">An et al 2012</xref>].</p>
        <p>CHCHD10 is ubiquitous and highly expressed in organs with high mitochondrial content such as the heart and liver. It is located in the intermembrane space of mitochondria, enriched at cristae junctions and plays a role in the maintenance of mitochondrial network [<xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>], the morphology of mitochondrial cristae, and the stability of mitochondrial DNA [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>]. CHCHD10 has also been shown to be involved in oxidative phosphorylation, and it possibly takes part in the function of complex IV of the respiratory chain [<xref ref-type="bibr" rid="chchd10-dis.REF.martherus.2010.203">Martherus et al 2010</xref>].</p>
        <p>CHCHD10 contains a conserved mitochondrial targeting signal, is highly co-expressed with other mitochondrial genes, and is transcriptionally activated during mitochondrial biogenesis [<xref ref-type="bibr" rid="chchd10-dis.REF.ajrouddriss.2015.1">Ajroud-Driss et al 2015</xref>]. The predicted model of CHCHD10 consists of a non-structured N-terminal region, a highly hydrophobic helix (amino acids 43-68), and the CHCH domain near the C-terminal region. The hydrophobic helix may function as an interface of interaction with other proteins and the four cysteine residues (102, 112, 122, 132) of the CHCH domain are involved in two disulfide bonds [<xref ref-type="bibr" rid="chchd10-dis.REF.bannwarth.2014.2329">Bannwarth et al 2014</xref>, <xref ref-type="bibr" rid="chchd10-dis.REF.penttil_.2015.163">Penttil&#x000e4; et al 2015</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Based on current knowledge the ways by which <italic toggle="yes">CHCHD10</italic> pathogenic variants could cause disease are by disorganizing mitochondrial cristae, impairing the mitochondrial network, and inducing deficiency in oxidative phosphorylation. Further functional analyses are required for understanding how <italic toggle="yes">CHCHD10</italic> pathogenic variants promote motor neuron disease (MND). Although there is no conclusive evidence to date, it appears that <italic toggle="yes">CHCHD10</italic> pathogenic variants are likely gain-of-function.</p>
      </sec>
      <sec id="chchd10-dis.References">
        <title>References</title>
        <sec id="chchd10-dis.Published_GuidelinesConsensu">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="chchd10-dis.Published_GuidelinesConsensu.reflist0">
            <ref id="chchd10-dis.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 10-20-16.</mixed-citation>
            </ref>
            <ref id="chchd10-dis.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 10-20-16.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="chchd10-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="chchd10-dis.Literature_Cited.reflist0">
            <ref id="chchd10-dis.REF.ajrouddriss.2015.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ajroud-Driss</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fecto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ajroud</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalani</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvo</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mootha</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>HX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddique</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahmoush</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heiman-Patterson</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddique</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy.</article-title>
                <source>Neurogenetics.</source>
                <year>2015</year>
                <volume>16</volume>
                <fpage>1</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25193783</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.an.2012.7411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>An</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lui</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheikh</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>CHM1/CHCHD6, a novel mitochondrial protein linked to regulation of mitofilin and mitochondrial cristae morphology.</article-title>
                <source>J Biol Chem</source>
                <year>2012</year>
                <volume>287</volume>
                <fpage>7411</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">22228767</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.bannwarth.2014.2329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bannwarth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ait-El-Mkadem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaussenot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genin</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacas-Gervais</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fragaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg-Alonso</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kageyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschueren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouzier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aug&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cochaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lespinasse</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N'Guyen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Septenville</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sesaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paquis-Flucklinger</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.</article-title>
                <source>Brain.</source>
                <year>2014</year>
                <volume>137</volume>
                <fpage>2329</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">24934289</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.bannwarth.2015.e377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bannwarth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ait-El-Mkadem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaussenot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genin</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacas-Gervais</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fragaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg-Alonso</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kageyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschueren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouzier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aug&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cochaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lespinasse</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N'Guyen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Septenville</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sesaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paquis-Flucklinger</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Reply: a distinct clinical phenotype in a German kindred with motor neuron disease carryig a CHCHD10 mutation.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e377</fpage>
                <pub-id pub-id-type="pmid">25681413</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.bird.1999.741">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poorkaj</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherrier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaye</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peskind</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampe</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemens</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyer</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <article-title>A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L).</article-title>
                <source>Brain.</source>
                <year>1999</year>
                <volume>122</volume>
                <fpage>741</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">10219785</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.brooks.2000.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swash</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munsat</surname>
                    <given-names>TL</given-names>
                  </name>
                </person-group>
                <article-title>World Federation of Neurology Research Group on Motor Neuron Diseases; El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.</article-title>
                <source>Amyotroph Lateral Scler Other Motor Neuron Disord.</source>
                <year>2000</year>
                <volume>1</volume>
                <fpage>293</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11464847</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.chaussenot.2014.2884.e1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaussenot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ait-El-Mkadem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Septenville</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bannwarth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genin</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aug&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>French research network on FTD and FTD-ALS, Brice A, Pouget J, Paquis-Flucklinger V. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.</article-title>
                <source>Neurobiol Aging.</source>
                <year>2014</year>
                <volume>35</volume>
                <fpage>2884.e1</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">25155093</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.darshi.2011.2918">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Darshi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendiola</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perkins</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellisman</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>SS</given-names>
                  </name>
                </person-group>
                <article-title>ChChd3, an inner mitochondrial membrane protein, is essential for maintening crista integrity and mitochondrial function.</article-title>
                <source>J Biol Chem</source>
                <year>2011</year>
                <volume>286</volume>
                <fpage>2918</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21081504</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.deakin.2004.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deakin</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nestor</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodges</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahakian</surname>
                    <given-names>BJ</given-names>
                  </name>
                </person-group>
                <article-title>Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.</article-title>
                <source>Psychopharmacology (Berl)</source>
                <year>2004</year>
                <volume>172</volume>
                <fpage>400</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14666399</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.dobsonstone.2015.e385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dobson-Stone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallupp</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartley</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCann</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loy</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mather</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kochan</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachdev</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliday</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piguet</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodges</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <article-title>Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e385</fpage>
                <pub-id pub-id-type="pmid">25953780</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.foster.2007.2616">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heidebrink</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jagust</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbas</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeCarli</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koeppe</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higdon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minoshima</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.</article-title>
                <source>Brain.</source>
                <year>2007</year>
                <month>Oct</month>
                <volume>130</volume>
                <issue>Pt 10</issue>
                <fpage>2616</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">17704526</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.foster.1997.706">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhelmsen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sima</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amato</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilman</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants.</article-title>
                <source>Ann Neurol.</source>
                <year>1997</year>
                <volume>41</volume>
                <fpage>706</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">9189031</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.gitcho.2008.535">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gitcho</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakraverty</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levitch</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatanpaa</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bigio</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caselli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Lozi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairns</surname>
                    <given-names>NJ</given-names>
                  </name>
                </person-group>
                <article-title>TDP-43 A315T mutation in familial motor neuron disease.</article-title>
                <source>Ann Neurol.</source>
                <year>2008</year>
                <volume>63</volume>
                <fpage>535</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18288693</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.gornotempini.2011.1006">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gorno-Tempini</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillis</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weintraub</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kertesz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappa</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogar</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohrer</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boeve</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manes</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dronkers</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandenberghe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rascovsky</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knopman</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodges</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesulam</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossman</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Classification of primary progressive aphasia and its variants.</article-title>
                <source>Neurology.</source>
                <year>2011</year>
                <volume>76</volume>
                <fpage>1006</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">21325651</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.johnson.2014.e311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glynn</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nalls</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabatelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Restagno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drory</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi&#x000f2;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traynor</surname>
                    <given-names>BJ</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis.</article-title>
                <source>Brain.</source>
                <year>2014</year>
                <volume>137</volume>
                <fpage>e311</fpage>
                <pub-id pub-id-type="pmid">25261972</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.k_hnlein.2008.1185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000fc;hnlein</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperfeld</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmassenhove</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deerlin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trojanowski</surname>
                    <given-names>JQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretzschmar</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations.</article-title>
                <source>Arch Neurol.</source>
                <year>2008</year>
                <volume>65</volume>
                <fpage>1185</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18779421</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.kurzwelly.2015.e376">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kurzwelly</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kr&#x000fc;ger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heneka</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e376</fpage>
                <pub-id pub-id-type="pmid">25681414</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.lebert.2004.355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lebert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stekke</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasenbroekx</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquier</surname>
                    <given-names>F.</given-names>
                  </name>
                </person-group>
                <article-title>Frontotemporal dementia: a randomised, controlled trial with trazodone.</article-title>
                <source>Dement Geriatr Cogn Disord.</source>
                <year>2004</year>
                <volume>17</volume>
                <fpage>355</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15178953</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.martherus.2010.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martherus</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sluiter</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmer</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>VanHerle</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayoubi</surname>
                    <given-names>TA</given-names>
                  </name>
                </person-group>
                <article-title>Functional annotation of heart enriched mitochondrial genes GBAS and CHCHD10 through guilt by association.</article-title>
                <source>Biochem Biophys Res Com</source>
                <year>2010</year>
                <volume>402</volume>
                <fpage>203</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20888800</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.miller.1999.1311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelinas</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsumoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sufit</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borasio</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromberg</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasarskis</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munsat</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oppenheimer</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <article-title>Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force.</article-title>
                <source>Neurology.</source>
                <year>1999</year>
                <volume>52</volume>
                <fpage>1311</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">10227612</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.mioshi.2010.1591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mioshi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsieh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornberger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodges</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <article-title>Clinical staging and disease progression in frontotemporal dementia.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>74</volume>
                <fpage>1591</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20479357</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.m_ller.2014.e309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000fc;bers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marroquin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volk</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danzer</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weishaupt</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <article-title>Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease.</article-title>
                <source>Brain.</source>
                <year>2014</year>
                <volume>137</volume>
                <fpage>e309</fpage>
                <pub-id pub-id-type="pmid">25113787</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.penttil_.2015.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Penttil&#x000e4;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jokela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouquin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saukkonen</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toivanen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Late onset spinal motor neuronopathy is caused by mutation in CHCHD10.</article-title>
                <source>Ann Neurol.</source>
                <year>2015</year>
                <volume>77</volume>
                <fpage>163</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">25428574</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.renton.2011.257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renton</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majounie</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waite</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon-Sanchez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rollinson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schymick</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laaksovirta</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Swieten</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllykangas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abramzon</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaganovich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholz</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duckworth</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harmer</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janel</surname>
                    <given-names>OJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mok</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryten</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trabzuni</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orrell</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sondervan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seelar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blake</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliwell</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennoin Callister</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toulson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerhard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snowden</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neary</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nalls</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peuralinna</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isoviita</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaivorrinne</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holtta-Vuori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikonen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sulkava</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benatar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Restagno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borghero</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabatelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <collab>The ITALSGEN Consortium</collab>
                </person-group>
                <article-title>Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 Is the cause of chromosome 9p21-linked ALS-FTD.</article-title>
                <source>Neuron.</source>
                <year>2011</year>
                <volume>72</volume>
                <fpage>257</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">21944779</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.ronchi.2015.e372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ronchi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riboldi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Bo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ticozzi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galimberti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <article-title>CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e372</fpage>
                <pub-id pub-id-type="pmid">25576308</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.schmitzh_bsch.2006.1717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schmitz-H&#x000fc;bsch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>du Montcel</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baliko</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berciano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boesch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depondt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Globas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Infante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melegh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rakowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribai</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rola</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szymanski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Warrenburg</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klockgether</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fancellu</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Scale for the assessment and rating of ataxia: development of a new clinical scale.</article-title>
                <source>Neurology.</source>
                <year>2006</year>
                <volume>66</volume>
                <fpage>1717</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16769946</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.traynor.2000.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Traynor</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Codd</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forde</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frost</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardiman</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Amyotrophic lateral sclerosis mimic syndromes: a population-based study.</article-title>
                <source>Arch Neurol.</source>
                <year>2000</year>
                <volume>57</volume>
                <fpage>109</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">10634456</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.van_swieten.1999.617">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Swieten</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosso</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joosse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Koning</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamphorst</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravid</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spillantini</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic variation in hereditary frontotemporal dementia with tau mutations.</article-title>
                <source>Ann Neurol.</source>
                <year>1999</year>
                <volume>46</volume>
                <fpage>617</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">10514099</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.wszolek.1992.312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatt</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schelper</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodnitzky</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolters</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arwert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                </person-group>
                <article-title>Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration.</article-title>
                <source>Ann Neurol.</source>
                <year>1992</year>
                <volume>32</volume>
                <fpage>312</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">1416801</pub-id>
              </element-citation>
            </ref>
            <ref id="chchd10-dis.REF.zhang.2015.e380">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maletta</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curcio</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rainero</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinessi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nacmias</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorbi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galimberti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surace</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreno</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traynor</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Mutation analysis of CHCHD10 in different neurodegenerative diseases.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e380</fpage>
                <pub-id pub-id-type="pmid">25833818</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="chchd10-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="chchd10-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>1 July 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>20 January 2015 (saem) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
